Although both authors did not focus on arteriosclerotic cardiovascular disease as the main outcome, Jha et al. (7) clearly demonstrated a significantly increased risk of death and pulmonary arterial hypertension in the presence of abnormally elevated CRP levels for SSc patients. The gene discussed is CRP; the disease is pulmonary arterial hypertension.